申请人:Asahi Kasei Pharma Corporation
公开号:EP1477472A1
公开(公告)日:2004-11-17
A compound represented by the formula (I) or a salt thereof
wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1(CH2)k- (wherein k represents 0 or an integer of 1 to 3; R1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.
由式(I)代表的化合物或其盐
其中 n 代表 1 至 3 的整数,R 代表具有 3 至 8 个碳原子的烷基,由下式代表的基团:R1(CH2)k- (其中 k 代表 0 或 1 至 3 的整数;R1 代表具有 3 至 7 个碳原子的饱和环状烷基或具有 6 至 8 个碳原子的饱和缩合环状烷基,该基团 R1 可被具有 1 至 4 个碳原子的低级烷基取代)等,Ar 代表缩合双环基团,例如萘-1-基团,该基团具有抑制前列腺素和白三烯生成的作用,可用于预防和/或治疗由这些脂质介质引起的各种炎症等。